June 23, 2020 / 11:42 AM / 9 days ago

Inovio gets $71 mln from U.S. DoD for COVID-19 vaccine device

June 23 (Reuters) - Inovio Pharmaceuticals Inc said on Tuesday it has received $71 million from the U.S. Department of Defense to scale up production of the company's devices that are used to administer its experimental COVID-19 vaccine into the skin.

Reporting by Manas Mishra in Bengaluru, Editing by Sherry Jacob-Phillips

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below